Environmental triggers which promote NF-κB signaling in the context of immunity-related risk genes for ALS/FTD [91,92,93], may lead to a failure to control the expression of this endogenous viral symbiont, thus facilitating ERVK CTXLP-driven neuropathology. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.